Minimization of the neuropathic effects of oxalipaltin administration agree to cost-effectiveness
WCRJ 2014; 1 (3): e264
Topic: Pharmacogenomics
Category: Editorial
To cite this article
Minimization of the neuropathic effects of oxalipaltin administration agree to cost-effectiveness
WCRJ 2014; 1 (3): e264
Publication History
Published online: 01 Oct 2014
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.